DE69314950T2 - Okulaerdarreichungsform und verfahren zu ihrer herstellung - Google Patents

Okulaerdarreichungsform und verfahren zu ihrer herstellung

Info

Publication number
DE69314950T2
DE69314950T2 DE69314950T DE69314950T DE69314950T2 DE 69314950 T2 DE69314950 T2 DE 69314950T2 DE 69314950 T DE69314950 T DE 69314950T DE 69314950 T DE69314950 T DE 69314950T DE 69314950 T2 DE69314950 T2 DE 69314950T2
Authority
DE
Germany
Prior art keywords
manufacture
dosage form
ocular dosage
ocular
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69314950T
Other languages
English (en)
Other versions
DE69314950D1 (de
Inventor
Jean-Marc Aiache
Gilbert Serpin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite dAuvergne
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9429535&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69314950(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of DE69314950D1 publication Critical patent/DE69314950D1/de
Application granted granted Critical
Publication of DE69314950T2 publication Critical patent/DE69314950T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69314950T 1992-05-05 1993-05-05 Okulaerdarreichungsform und verfahren zu ihrer herstellung Expired - Lifetime DE69314950T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9205514A FR2690846B1 (fr) 1992-05-05 1992-05-05 Forme galenique pour administration oculaire et procede de preparation.
PCT/FR1993/000433 WO1993021901A1 (fr) 1992-05-05 1993-05-05 Forme galenique pour administration oculaire et procede de preparation

Publications (2)

Publication Number Publication Date
DE69314950D1 DE69314950D1 (de) 1997-12-04
DE69314950T2 true DE69314950T2 (de) 1998-04-16

Family

ID=9429535

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69314950T Expired - Lifetime DE69314950T2 (de) 1992-05-05 1993-05-05 Okulaerdarreichungsform und verfahren zu ihrer herstellung

Country Status (8)

Country Link
US (1) US5766619A (de)
EP (1) EP0639069B1 (de)
JP (1) JP3208568B2 (de)
KR (1) KR100206481B1 (de)
DE (1) DE69314950T2 (de)
ES (1) ES2109493T3 (de)
FR (1) FR2690846B1 (de)
WO (1) WO1993021901A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19511322C2 (de) 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
EP1154691A4 (de) * 1999-01-05 2004-07-07 Massachusetts Eye & Ear Infirm Gezielte transsklerale gesteuerte wirkstoffabgabe an die retina und choroidae
US7943162B2 (en) * 1999-10-21 2011-05-17 Alcon, Inc. Drug delivery device
US6416777B1 (en) * 1999-10-21 2002-07-09 Alcon Universal Ltd. Ophthalmic drug delivery device
EP1522289A3 (de) 1999-10-21 2008-01-23 Alcon, Inc Untersehnenmedikamentenversorgung.
PT1221917E (pt) 1999-10-21 2005-04-29 Alcon Inc Dispositivo para ministrar medicamentos
US7563255B2 (en) 2001-05-03 2009-07-21 Massachusetts Eye And Ear Infirmary Implantable drug delivery device and use thereof
EP1385452B1 (de) * 2001-07-23 2006-09-13 Alcon, Inc. Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
WO2003009774A2 (en) 2001-07-23 2003-02-06 Alcon, Inc. Ophthalmic drug delivery device
WO2003092665A2 (en) * 2002-05-02 2003-11-13 Massachusetts Eye And Ear Infirmary Ocular drug delivery systems and use thereof
WO2004073551A2 (en) * 2003-02-18 2004-09-02 Massachusetts Eye And Ear Infirmary Transscleral drug delivery device and related methods
EP1682132A1 (de) * 2003-09-18 2006-07-26 Macusight, Inc. Transsklerale abgabe
US8663639B2 (en) * 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
AU2006213673A1 (en) * 2005-02-09 2006-08-17 Santen Pharmaceutical Co., Ltd. Formulations for ocular treatment
JP2009502954A (ja) 2005-07-27 2009-01-29 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド タンパク質のミスフォールディングを修正する小分子及びその使用
CN101232902B (zh) * 2005-07-29 2013-04-17 参天制药株式会社 使用固态组合物的对后眼部组织的非侵袭性药物传递***
PL1968594T3 (pl) 2005-11-29 2011-03-31 Glaxosmithkline Llc Leczenie zaburzeń neowaskularyzacyjnych oka, takich jak zwyrodnienie plamki żółtej, rozszerzenie naczyń siatkówki w zespole Hippla i Lindaua, zapalenie błony naczyniowej oka i obrzęk plamki
CA2635797C (en) 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
JP5506378B2 (ja) 2006-03-23 2014-05-28 参天製薬株式会社 血管透過性に関連する疾患または病気のための製剤および方法
US20080265343A1 (en) * 2007-04-26 2008-10-30 International Business Machines Corporation Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
US8372036B2 (en) 2009-05-06 2013-02-12 Alcon Research, Ltd. Multi-layer heat assembly for a drug delivery device
IN2012DN00352A (de) 2009-06-16 2015-08-21 Bikam Pharmaceuticals Inc
WO2011039648A1 (en) 2009-09-30 2011-04-07 Glaxo Wellcome Manufacturing Pte Ltd. Methods of administration and treatment
US8177747B2 (en) 2009-12-22 2012-05-15 Alcon Research, Ltd. Method and apparatus for drug delivery
WO2012174064A1 (en) 2011-06-14 2012-12-20 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
US9499464B2 (en) 2011-10-19 2016-11-22 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
US9353063B2 (en) 2011-11-30 2016-05-31 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
AU2012346537A1 (en) 2011-12-01 2014-07-17 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
CN109549922B (zh) * 2018-12-27 2021-04-20 湖北远大天天明制药有限公司 一种托吡卡胺眼用组合物及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3630200A (en) * 1969-06-09 1971-12-28 Alza Corp Ocular insert
SE352811B (de) * 1971-06-04 1973-01-15 Pharmacia Ab
US3986510A (en) * 1971-09-09 1976-10-19 Alza Corporation Bioerodible ocular device
US3828777A (en) * 1971-11-08 1974-08-13 Alza Corp Microporous ocular device

Also Published As

Publication number Publication date
EP0639069B1 (de) 1997-10-29
US5766619A (en) 1998-06-16
ES2109493T3 (es) 1998-01-16
KR100206481B1 (en) 1999-07-01
JPH07506356A (ja) 1995-07-13
EP0639069A1 (de) 1995-02-22
FR2690846A1 (fr) 1993-11-12
DE69314950D1 (de) 1997-12-04
KR950701214A (ko) 1995-03-23
FR2690846B1 (fr) 1995-07-07
WO1993021901A1 (fr) 1993-11-11
JP3208568B2 (ja) 2001-09-17

Similar Documents

Publication Publication Date Title
DE69314950T2 (de) Okulaerdarreichungsform und verfahren zu ihrer herstellung
DE59606535D1 (de) Furnacerusse und Verfahren zu ihrer Herstellung
DE69327743D1 (de) Sekundärbatterie und Verfahren zu ihrer Herstellung
DE69310402T2 (de) Beschichtungszusammensetzung und Verfahren zu ihrer Herstellung
DE69411604T2 (de) Wirkstoffzusammensetzung und Verfahren zu ihrer Herstellung
DE69306615T2 (de) Verbundwalze und Verfahren zu ihrer Herstellung
DE69127949D1 (de) Thyristor und Verfahren zu dessen Herstellung
DE69216772D1 (de) Medizinische Behälter und Verfahren zu ihrer Herstellung
DE69423082T2 (de) Supraleiter und Verfahren zu dessen Herstellung
DE69332117D1 (de) 4-diphenylmethylpiperidine und verfahren zu ihrer herstellung
DE69301771T2 (de) T-Butyl-R-(-)-4-cyano-3-hydroxybutyrat und Verfahren zu seiner Herstellung
DE69106627D1 (de) Oligohexafluorpropylenverbindungen und Verfahren zu ihrer Herstellung.
DE69114420D1 (de) Organozyklosiloxane und Verfahren zu ihrer Herstellung.
DE69306279T2 (de) 3-Aryl-Glycidsäureester und Verfahren zu ihrer Herstellung
DE69017091T2 (de) Cyclomalto-oligosaccharidderivate und Verfahren zu ihrer Herstellung.
DE59206999D1 (de) Oxadimethacryl-Verbindungen und Verfahren zu ihrer Herstellung
DE69227419T2 (de) Cermet-Elektrode und Verfahren zu ihrer Herstellung
DE69212920D1 (de) Oligohexafluoropropylenverbindungen und Verfahren zu ihrer Herstellung
DE68914500T2 (de) Alkylarylsulfone und Verfahren zu ihrer Herstellung.
ATA123792A (de) Artilleriegranate und verfahren zu ihrer herstellung
DE59304565D1 (de) 2-Methyl-3-chlorpropyl-cyclohexyldialkoxysilane und Verfahren zu ihrer Herstellung
DE69326440T2 (de) Prothese und Verfahren zu ihrer Herstellung
DE69406183D1 (de) Jodvitamin-D-Verbindungen und Verfahren zu ihrer Herstellung
DE59206227D1 (de) 2-Methyl-3-chlorpropyl-cyclohexyldichlorsilan und Verfahren zu dessen Herstellung
DE69606662D1 (de) Dianilinoglutacondialdehyd-Verbindungen und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: L' UNIVERSITE D'AUVERGNE ETABLISSEMENT PUBLIC , FR

8381 Inventor (new situation)

Inventor name: AIACHE, JEAN-MARC, CLERMONT-FERRAND, FR

Inventor name: SERPIN, GILBERT, CLERMONT-FERRAND, FR